Bittium Corporation
Financial Calendar

Bittium Corporation’s Financial Calendar for the Year 2024

Bittium Corporation, Stock Exchange Release, December 13, 2023, at 2.15 pm (CET+1)

In 2024, Bittium Corporation will publish its half year financial report, annual financial report, and Business Reviews from the financial periods of January-March and January-September. The structure of the Business Reviews is lighter than that of the financial reports.

In 2024, Bittium Corporation will publish its half year financial report and Financial Statement Bulletin as follows:

• Financial Statement Bulletin 2023: on February 9, 2024, at 8.00 am (CET+1)
• Half Year Financial Report January-June 2024: on August 9, 2024, at 8.00 am (CEST+1)

In 2024, Bittium Corporation will publish its Business Reviews as follows:

• Business Review January-March 2024: on April 26, 2024, at 8.00 am (CET+1)
• Business Review January-September 2024: on October 18, 2024, at 8.00 am (CET+1)

Bittium Corporation observes a three-week silent period prior to announcing its financial reports. In 2024 the silent periods are as follows:

• January 19 - February 9, 2024
• April 5 – April 26, 2024
• July 19 – August 9, 2024
• September 27 – October 18, 2024

Bittium will release its annual report 2023 including Corporate Governance and Sustainability Report on March 20, 2024.

The Annual General Meeting will be held in Oulu, Finland on April 10, 2024.

Oulu, December 13, 2023
Bittium Corporation

Further information:

Karoliina Malmi
Vice President, Corporate Communications and ESG
Tel. +358 40 344 2789

Distribution

Nasdaq Helsinki Oy
Main media

Bittium

Bittium specializes in the development of reliable, secure communications and connectivity solutions leveraging its over 35-year legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and services, customized solutions based on its product platforms, and R&D services. Complementing its communications and connectivity solutions, Bittium offers proven information security solutions for mobile devices and portable computers. Bittium also provides healthcare technology products and services for biosignal measuring in the areas of cardiology and neurophysiology. Net sales in 2022 were EUR 82.5 million and operating profit was EUR 0.3 million. Bittium is listed on Nasdaq Helsinki. www.bittium.com

Files
Bittium Corporation's Financial Calendar for the Year 2024 (wkr0006.pdf)